Irreversibly glycated LDL induce oxidative and inflammatory state in human endothelial cells; added effect of high glucose

• Published in: Biochemical and biophysical research communications Vol. 390; no. 3; pp. 877 - 882
• Main Authors: Toma, Laura, Stancu, Camelia S., Botez, Gabriela M., Sima, Anca V., Simionescu, Maya
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 18.12.2009
• Subjects: Cell Line; Cell Proliferation; Chemokine CCL2 - metabolism; Endothelial cell; Endothelium, Vascular - metabolism; Endothelium, Vascular - pathology; Gene Expression; Glucose - metabolism; Glucose - pharmacology; Glycated LDL; Glycation End Products, Advanced - metabolism; Glycation End Products, Advanced - pharmacology; Humans; Hyperglycemia - metabolism; Hyperglycemia - pathology; Imidazoles - pharmacology; Inflammation - metabolism; Inflammation - pathology; Lipoproteins, LDL - metabolism; Lipoproteins, LDL - pharmacology; MCP-1; NADPH oxidase; NADPH Oxidase 4; NADPH Oxidases - metabolism; Nitriles - pharmacology; p22 phox; Pyridines - pharmacology; RAGE; Receptor for Advanced Glycation End Products; Receptors, Immunologic - metabolism; Sulfones - pharmacology; Glycated LDL; Endothelial cell; MCP-1; RAGE; p22 phox; NADPH oxidase
• ISSN: 0006-291X; 1090-2104
• DOI: 10.1016/j.bbrc.2009.10.066

In diabetes, hyperglycemia and the associated formation of advanced glycation end-products (AGE) and AGE-modified low density lipoproteins (AGE-LDL) can directly affect the cells of the vascular wall. We hypothesize that AGE-LDL may act directly and induce oxidant and inflammatory alterations in human endothelial cells (HEC), this effect being amplified by high glucose. To test this assumption, the activity of NADPH oxidase (NADPHox) was evaluated and the expression of its subunits (p22 phox, NOX4, and p67 phox), of the AGE receptor (RAGE), and of the monocyte chemoattractant protein-1 (MCP-1) were assessed by real-time PCR and Western blot in confluent EA.hy926 cells incubated with AGE-LDL for 24 and 48 h, in normal and high glucose conditions. Exposure of HEC for 48 h to AGE-LDL in 5 mM glucose induced an increase of RAGE expression (50%), NADPHox activity (107%), p22 phox and NOX4 mRNA (50% and 188%, respectively) and MCP-1 expression (80%). AGE-LDL-stimulated p22 phox expression by activating p38 MAP kinase and NF-kB, and MCP-1 expression by activating NF-kB, as demonstrated by the use of specific inhibitors (SB203580 and Bay11-7085). The addition of 25 mM glucose in the culture medium enhanced the effect of AGE-LDL, but also of nLDL, on RAGE, p22 phox, NOX4, p67 phox, and MCP-1 gene expression. In conclusion, AGE-LDL induce an oxidative stress and a pro-inflammatory state in human endothelial cells. Both AGE-LDL and nLDL in the presence of high glucose amplify their effect, revealing a link between hyperlipidemia, diabetes, and endothelial cell dysfunction.